McKesson Corporation (LON:0JZU)
London flag London · Delayed Price · Currency is GBP · Price in USD
825.99
+15.59 (1.92%)
At close: Dec 19, 2025

McKesson Revenue

McKesson had revenue of $103.15B USD in the quarter ending September 30, 2025, with 10.14% growth. This brings the company's revenue in the last twelve months to $387.09B, up 17.23% year-over-year. In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth.

Revenue (ttm)
$387.09B
Revenue Growth
+17.23%
P/S Ratio
0.26
Revenue / Employee
$8.60M
Employees
45,000
Market Cap
75.70B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025359.05B50.10B16.22%
Mar 31, 2024308.95B32.24B11.65%
Mar 31, 2023276.71B12.75B4.83%
Mar 31, 2022263.97B25.74B10.80%
Mar 31, 2021238.23B7.18B3.11%
Mar 31, 2020231.05B16.73B7.81%
Mar 31, 2019214.32B5.96B2.86%
Mar 31, 2018208.36B9.82B4.95%
Mar 31, 2017198.53B7.65B4.01%
Mar 31, 2016190.88B11.84B6.61%
Mar 31, 2015179.05B41.65B30.32%
Mar 31, 2014137.39B15.20B12.44%
Mar 31, 2013122.20B-125.00M-0.10%
Mar 31, 2012122.32B10.24B9.13%
Mar 31, 2011112.08B3.38B3.11%
Mar 31, 2010108.70B2.07B1.94%
Mar 31, 2009106.63B4.93B4.85%
Mar 31, 2008101.70B8.73B9.39%
Mar 31, 200792.98B5.99B6.89%
Mar 31, 200686.98B7.89B9.97%
Mar 31, 200579.10B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.24B
GSK plc32.17B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
Convatec Group1.72B
Genus672.80M
HUTCHMED (China)439.54M
Revenue Rankings